Detection of Memory B Activity Against a Therapeutic Protein in Treatment-Naïve Subjects
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmaceutical Science
Link
http://link.springer.com/article/10.1208/s12248-018-0198-5/fulltext.html
Reference38 articles.
1. Koren E, Zuckerman L, Mire-Sluis A. Immune responses to therapeutic proteins in humans-clinical significance, assessment and prediction. Curr Pharm Biotechnol. 2002;3(4):349–60. https://doi.org/10.2174/1389201023378175 .
2. Schellekens H, Casadevall N. Immunogenicity of recombinant human proteins: causes and consequences. Journal of neurology. 2004; 251(2):ii4-ii9.
3. Wolbink GJ, Aarden LA, Dijkmans BAC. Dealing with immunogenicity of biologicals: assessment and clinical relevance. Curr Opin Rheumatol. 2009;21(3):211–5. https://doi.org/10.1097/BOR.0b013e328329ed8b .
4. Casadevall N, Nataf J, Viron B, Kolta A, Kiladjian J-J, Martin-Dupont P, et al. Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N Engl J Med. 2002;346(7):469–75. https://doi.org/10.1056/NEJMoa011931 .
5. Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M, et al. Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 2001;98(12):3241–8. https://doi.org/10.1182/blood.V98.12.3241 .
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of Immune Responses to Oxidation, Deamidation, And Isomerization in Therapeutic Antibodies using Preclinical Immunogenicity Risk Assessment Assays;Journal of Pharmaceutical Sciences;2022-08
2. Immunogenicity assessment of bispecific antibody-based immunotherapy in oncology;Journal for ImmunoTherapy of Cancer;2022-04
3. Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays;mAbs;2021-12-20
4. Characterization of the robust humoral immune response to GSK2618960, a humanized anti-IL-7 receptor monoclonal antibody, observed in healthy subjects in a Phase 1 study;PLOS ONE;2021-03-23
5. Nonclinical immunogenicity risk assessment of therapeutic proteins;Bioanalysis;2019-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3